Article

PD-L1 expression in 522 selected sarcomas with subset analysis of recurrent or metastatic matched samples and association with tumour-infiltrating lymphocytes

2019-09-04

Abstract excerpt

We assessed the frequency of programmed death-ligand 1 (PD-L1) expression by immunohistochemistry (IHC) in a cohort of 522 sarcomas from 457 patients, incuding a subset of 46 patients with 63 matched samples from local recurrence or metastases with primary tumours and/or metachronous metastases. We also investigated the correlation of PD-L1 with the presence and degree of tumour-infiltrating lymphocytes (TILs) in...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 5fe4f888-a553-5a6c-84ca-a217490c038a
DOI: 10.1101/757625

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

PD-L1 expression in 522 selected sarcomas with subset analysis of recurrent or metastatic matched samples and association with tumour-infiltrating lymphocytesDOI 10.1101/757625Read

The proteomic landscape of soft tissue sarcomasSemantic proximity Read

Update on genomic and molecular landscapes of well-differentiated liposarcoma and dedifferentiated liposarcoma.Semantic proximity Read

PD-L1 (CD274) copy number gain, expression, and immune cell infiltration as candidate predictors for response to immune checkpoint inhibitors in soft-tissue sarcomaSemantic proximity Read

Comprehensive Immuno-Molecular Profiles for Liposarcoma: Roles of Programmed Death Ligand 1, Microsatellite Instability, and PIK3CA.Semantic proximity Read

Pleomorphic liposarcoma: clinical observations and molecular variables.Semantic proximity Read

New developments in the pathology and molecular biology of retroperitoneal sarcomasSemantic proximity Read

CD4+ T cell and M2 macrophage infiltration predict dedifferentiated liposarcoma patient outcomesSemantic proximity Read

Loss of PTEN Is Associated with Resistance to Anti-PD-1 Checkpoint Blockade Therapy in Metastatic Uterine Leiomyosarcoma.Semantic proximity Read

Dedifferentiated LiposarcomaSemantic proximity Read

Targeting liposarcoma: unveiling molecular pathways and therapeutic opportunitiesSemantic proximity Read

MicroRNA profiling of primary high‐grade soft tissue sarcomasSemantic proximity Read

Distinct immunologic patterns of response and resistance to anti-PD-1/PD-L1-based immunotherapy in patients with soft tissue sarcoma.Semantic proximity Read